The Opportunity

Abbott has entered into an agreement to purchase Synlait’s North Island assets in New Zealand, including the Pōkeno manufacturing facility. Acquiring this facility supports Abbott’s anticipated growth in the Pacific Asia region across our adult and pediatric nutrition products. The pending close of the agreement is April 1, 2026.

This position works out of our Pokeno Site location in the Nutrition Division.

As the Validation Transformation Lead, QA

What You’ll Do

• Validation Transformation & Strategy: Lead enterprise or site-level validation transformation initiatives to address regulatory findings and business risks while establishing a sustainable future-state validation framework.
• Remediation Execution & Integration: Drive execution of validation remediation activities across process validation, cleaning validation, equipment and utility qualification, facilities qualification, and computerized system...